Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients

Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.12405-12406
Hauptverfasser: Labrador, Jorge, Cuevas, Maria Victoria, Alonso-Madrigal, Cristina, Zubiaur, Pablo, Azibeiro, Raul, Cuevas, Beatriz, Alvarez, Rodolfo, Diaz-Galvez, Francisco Javier, Gonzalez-Lopez, Tomas Jose, Alcaraz, Raquel, Mejía-Abril, Gina Paola, Loscertales, Javier, Abad, Francisco, Saiz-Rodríguez, Miriam
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12406
container_issue Supplement 1
container_start_page 12405
container_title Blood
container_volume 140
creator Labrador, Jorge
Cuevas, Maria Victoria
Alonso-Madrigal, Cristina
Zubiaur, Pablo
Azibeiro, Raul
Cuevas, Beatriz
Alvarez, Rodolfo
Diaz-Galvez, Francisco Javier
Gonzalez-Lopez, Tomas Jose
Alcaraz, Raquel
Mejía-Abril, Gina Paola
Loscertales, Javier
Abad, Francisco
Saiz-Rodríguez, Miriam
description
doi_str_mv 10.1182/blood-2022-163176
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_163176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122072378</els_id><sourcerecordid>S0006497122072378</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1376-63fff555e31e470601754efff129c021311deda8b99325fcea673366052d5c1e3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQQIMouK7-AG_9A9WZpEm3eJLFj4WCC67nkKZTN7ptljQV--_tup49DQzzhsdj7BrhBnHBb6ud93XKgfMUlcBcnbAZSr5IATicshkAqDQrcjxnF33_AYCZ4HLGNuutCa2x_p06is4mr3Gox8Q3yaoKQ3Sdq5KN_3bWxTFxXbLcBt9NZ-XY7rfejgekpOGTWmeStYmOuthfsrPG7Hq6-ptz9vb4sFk-p-XL02p5X6YWRa5SJZqmkVKSQMpyUIC5zGjaIS8scBSINdVmURXF5NpYMioXQimQvJYWScwZHv_a4Ps-UKP3wbUmjBpBH7Lo3yz6kEUfs0zM3ZGhSezLUdC9naQt1S6Qjbr27h_6B75ba1Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Labrador, Jorge ; Cuevas, Maria Victoria ; Alonso-Madrigal, Cristina ; Zubiaur, Pablo ; Azibeiro, Raul ; Cuevas, Beatriz ; Alvarez, Rodolfo ; Diaz-Galvez, Francisco Javier ; Gonzalez-Lopez, Tomas Jose ; Alcaraz, Raquel ; Mejía-Abril, Gina Paola ; Loscertales, Javier ; Abad, Francisco ; Saiz-Rodríguez, Miriam</creator><creatorcontrib>Labrador, Jorge ; Cuevas, Maria Victoria ; Alonso-Madrigal, Cristina ; Zubiaur, Pablo ; Azibeiro, Raul ; Cuevas, Beatriz ; Alvarez, Rodolfo ; Diaz-Galvez, Francisco Javier ; Gonzalez-Lopez, Tomas Jose ; Alcaraz, Raquel ; Mejía-Abril, Gina Paola ; Loscertales, Javier ; Abad, Francisco ; Saiz-Rodríguez, Miriam</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-163176</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.12405-12406</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Labrador, Jorge</creatorcontrib><creatorcontrib>Cuevas, Maria Victoria</creatorcontrib><creatorcontrib>Alonso-Madrigal, Cristina</creatorcontrib><creatorcontrib>Zubiaur, Pablo</creatorcontrib><creatorcontrib>Azibeiro, Raul</creatorcontrib><creatorcontrib>Cuevas, Beatriz</creatorcontrib><creatorcontrib>Alvarez, Rodolfo</creatorcontrib><creatorcontrib>Diaz-Galvez, Francisco Javier</creatorcontrib><creatorcontrib>Gonzalez-Lopez, Tomas Jose</creatorcontrib><creatorcontrib>Alcaraz, Raquel</creatorcontrib><creatorcontrib>Mejía-Abril, Gina Paola</creatorcontrib><creatorcontrib>Loscertales, Javier</creatorcontrib><creatorcontrib>Abad, Francisco</creatorcontrib><creatorcontrib>Saiz-Rodríguez, Miriam</creatorcontrib><title>Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQQIMouK7-AG_9A9WZpEm3eJLFj4WCC67nkKZTN7ptljQV--_tup49DQzzhsdj7BrhBnHBb6ud93XKgfMUlcBcnbAZSr5IATicshkAqDQrcjxnF33_AYCZ4HLGNuutCa2x_p06is4mr3Gox8Q3yaoKQ3Sdq5KN_3bWxTFxXbLcBt9NZ-XY7rfejgekpOGTWmeStYmOuthfsrPG7Hq6-ptz9vb4sFk-p-XL02p5X6YWRa5SJZqmkVKSQMpyUIC5zGjaIS8scBSINdVmURXF5NpYMioXQimQvJYWScwZHv_a4Ps-UKP3wbUmjBpBH7Lo3yz6kEUfs0zM3ZGhSezLUdC9naQt1S6Qjbr27h_6B75ba1Y</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Labrador, Jorge</creator><creator>Cuevas, Maria Victoria</creator><creator>Alonso-Madrigal, Cristina</creator><creator>Zubiaur, Pablo</creator><creator>Azibeiro, Raul</creator><creator>Cuevas, Beatriz</creator><creator>Alvarez, Rodolfo</creator><creator>Diaz-Galvez, Francisco Javier</creator><creator>Gonzalez-Lopez, Tomas Jose</creator><creator>Alcaraz, Raquel</creator><creator>Mejía-Abril, Gina Paola</creator><creator>Loscertales, Javier</creator><creator>Abad, Francisco</creator><creator>Saiz-Rodríguez, Miriam</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients</title><author>Labrador, Jorge ; Cuevas, Maria Victoria ; Alonso-Madrigal, Cristina ; Zubiaur, Pablo ; Azibeiro, Raul ; Cuevas, Beatriz ; Alvarez, Rodolfo ; Diaz-Galvez, Francisco Javier ; Gonzalez-Lopez, Tomas Jose ; Alcaraz, Raquel ; Mejía-Abril, Gina Paola ; Loscertales, Javier ; Abad, Francisco ; Saiz-Rodríguez, Miriam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1376-63fff555e31e470601754efff129c021311deda8b99325fcea673366052d5c1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Labrador, Jorge</creatorcontrib><creatorcontrib>Cuevas, Maria Victoria</creatorcontrib><creatorcontrib>Alonso-Madrigal, Cristina</creatorcontrib><creatorcontrib>Zubiaur, Pablo</creatorcontrib><creatorcontrib>Azibeiro, Raul</creatorcontrib><creatorcontrib>Cuevas, Beatriz</creatorcontrib><creatorcontrib>Alvarez, Rodolfo</creatorcontrib><creatorcontrib>Diaz-Galvez, Francisco Javier</creatorcontrib><creatorcontrib>Gonzalez-Lopez, Tomas Jose</creatorcontrib><creatorcontrib>Alcaraz, Raquel</creatorcontrib><creatorcontrib>Mejía-Abril, Gina Paola</creatorcontrib><creatorcontrib>Loscertales, Javier</creatorcontrib><creatorcontrib>Abad, Francisco</creatorcontrib><creatorcontrib>Saiz-Rodríguez, Miriam</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Labrador, Jorge</au><au>Cuevas, Maria Victoria</au><au>Alonso-Madrigal, Cristina</au><au>Zubiaur, Pablo</au><au>Azibeiro, Raul</au><au>Cuevas, Beatriz</au><au>Alvarez, Rodolfo</au><au>Diaz-Galvez, Francisco Javier</au><au>Gonzalez-Lopez, Tomas Jose</au><au>Alcaraz, Raquel</au><au>Mejía-Abril, Gina Paola</au><au>Loscertales, Javier</au><au>Abad, Francisco</au><au>Saiz-Rodríguez, Miriam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>12405</spage><epage>12406</epage><pages>12405-12406</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-163176</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.12405-12406
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_163176
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T06%3A23%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacogenetic%20Study%20of%20Ibrutinib%20Toxicity%20in%20Chronic%20Lymphocytic%20Leukemia%20Patients&rft.jtitle=Blood&rft.au=Labrador,%20Jorge&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=12405&rft.epage=12406&rft.pages=12405-12406&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-163176&rft_dat=%3Celsevier_cross%3ES0006497122072378%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122072378&rfr_iscdi=true